Clinical reality is that no two people with the same diagnosis are the same in terms of brain features, symptoms, social determinants, etc. Embracing variability in the search for biological mechanisms of psychiatric illness: Trends in Cognitive Sciences cell.com/trends/cogniti…

CAMH spin-off company Kelello Health is a measurement-based care platform transforming the delivery of #mentalhealth care. We’re thrilled to share that Kelello Health has been awarded $100K through a competitive funding grant from Ontario Brain Institute!🎉 MORE: braininstitute.ca/news-events/20…

On #RemembranceDay, we honour all those who fought for freedom and those who made the ultimate sacrifice. We also acknowledge the tragic psychological effects on all who were involved. Courage exists in many forms. There is bravery in seeking help and support in times of crisis.

Congratulations to Dr. Nicole Kozloff of @camhnews on winning the Glenda MacQueen Award from CanPsychiatricAssoc and CIHR-INMHA // INSMT des IRSC ! Dr. Kozloff has dedicated her career to improving health services for #youth with severe #mentalillness.

Could embracing analytical variability in neuroimaging be the key to more robust and generalizable scientific discoveries? Check out the latest by Greg Kiar, tingster, NeuroData Lab, Tristan Glatard and Jeanette Mumford for insights: rdcu.be/dZ0HA nature.com/articles/s4146…

Our only speaker for November will be next week, Nov 20, 130PM EST: Aristotle Voineskos with talk titled, "Neuroimaging Approaches in Clinical Trials" at the usual zoom link. If not on our email list, please DM your email and we'll send the link.🧠

The main public health message here is that if someone experiences ongoing symptoms of psychosis after using substances (mushrooms, cannabis, anything), there should be a clear recommendation not to use again. Because the risk of developing schizophrenia is high for that person.

Unfortunately re-learning the lessons of the '60s & '70s when hallucinogen use was clearly identified as a risk factor for schizophrenia. These data show that for some people any hallucinogen use is unsafe, and yet rate of use recently has doubled especially among younger people.

Toronto hospital selected as first Canadian site for CAN-PRIME study, testing out Elon Musk ⁦Neuralink⁩ to help people who can’t move limbs because of paralysis or disease. ⁦CTV News⁩ ⁦University Health Network⁩ uhn.ca/Corporate/News…

We’re excited to share that Louis Busch ᐋᐧᐋᐧᐦᑌᐃᐧ ᒥᐢᑕᑎᒼ, Community Support Specialist, has won the 2024 SSHRC Talent Award in recognition of his doctoral research empowering #Indigenous communities by preserving and promoting community-helping practices. MORE: sshrc-crsh.gc.ca/results-result…

Congratulations to Dr. Neil Vasdev, CAMH and UofTPsychiatry, for his reappointment as Canada Research Chair – Tier 1 in Radiochemistry and Medical Imaging. #IMSFaculty utoronto.ca/celebrates/42-…

A doctor, scientist & author of more than 600 papers, Dr. Mary Seeman lived a remarkable life. In a The Canadian Journal of Psychiatry obituary, she is remembered "as an inspiring teacher, a caring mentor, an indefatigable researcher & writer, and a compassionate clinician." journals.sagepub.com/doi/full/10.11…

UHN is proud to be ranked #1 on the list of Canada’s Top 40 Research Hospitals from Research Infosource for the 14th year in a row! Thanks to our incredible research community for their continued dedication to #HealthDiscovery, #care & #education! 🔗uhnresearch.ca/news/uhn-iscan…

CAMH is Canada’s Top Mental Health Research Hospital - Research spending surpasses $100 million, signaling unprecedented investment in mental health science and care. camh.ca/en/camh-news-a…

CAMH has been ranked #Canada’s Top Mental Health Research Hospital according to the latest Research Infosource rankings! 🏆 With over $100M in #research spending in 2022-2023, we’re leading the way in #MentalHealth science & #innovation. Read more: researchinfosource.com/top-40-researc…

Thank you ACNP and the award committee for this tremendous recognition. Very grateful.

UHN is excited to announce the adoption of the Ontario Universal Agreement for Clinical Trials—an initiative designed to accelerate clinical trial processes.✨ With this agreement, we remain committed to creating #AHealthierWorld for all. Learn more➡️ ctontario.ca/universal-agre…

A first-of-its-kind CAMH-led study published in @socscimed explores the systemic barriers and ethical complexities regarding #cannabis research funded by the for-profit cannabis industry: MORE: camh.ca/en/camh-news-a…

A record round of funding from CIHR for @camhnews !

Time for 🇨🇦 to Lead.